References
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108 https://doi.org/10.3322/caac.21262
- Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004;126:1005-1014 https://doi.org/10.1053/j.gastro.2003.12.049
- Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122-130 https://doi.org/10.1053/j.gastro.2005.04.009
- Lencioni R. Loco-regional treatment of hepatocellular carcinoma. Hepatology 2010;52:762-773 https://doi.org/10.1002/hep.23725
- N'Kontchou G, Mahamoudi A, Aout M, Ganne-Carrie N, Grando V, Coderc E, et al. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009;50:1475-1483 https://doi.org/10.1002/hep.23181
- Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000;214:761-768 https://doi.org/10.1148/radiology.214.3.r00mr02761
- McGhana JP, Dodd GD 3rd. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 2001;176:3-16 https://doi.org/10.2214/ajr.176.1.1760003
- Idee JM, Guiu B. Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review. Crit Rev Oncol Hematol 2013;88:530-549 https://doi.org/10.1016/j.critrevonc.2013.07.003
- Maluccio MA, Covey AM, Porat LB, Schubert J, Brody LA, Sofocleous CT, et al. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 2008;19:862-869 https://doi.org/10.1016/j.jvir.2008.02.013
- Min JH, Lee MW, Cha DI, Jeon YH, Shin SW, Cho SK, et al. Radiofrequency ablation combined with chemoembolization for intermediate-sized (3-5 cm) hepatocellular carcinomas under dual guidance of biplane fluoroscopy and ultrasonography. Korean J Radiol 2013;14:248-258 https://doi.org/10.3348/kjr.2013.14.2.248
- Takaki H, Yamakado K, Uraki J, Nakatsuka A, Fuke H, Yamamoto N, et al. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. J Vasc Interv Radiol 2009;20:217-224 https://doi.org/10.1016/j.jvir.2008.10.019
- Chang NK, Shin SS, Kim JW, Kim HJ, Jeong YY, Heo SH, et al. Effect of ultrasound-guided radiofrequency ablation in incompletely treated hepatocellular carcinoma after transcatheter arterial chemoembolization. Korean J Radiol 2012;13 Suppl 1:S104-S111 https://doi.org/10.3348/kjr.2012.13.S1.S104
- Kim JW, Shin SS, Kim JK, Choi SK, Heo SH, Lim HS, et al. Radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of single hepatocellular carcinoma of 2 to 5 cm in diameter: comparison with surgical resection. Korean J Radiol 2013;14:626-635 https://doi.org/10.3348/kjr.2013.14.4.626
- Hu YQ. Radiofrequency ablation and transcatheter arterial chemoembolization in primary hepatic carcinoma. Contemp Med 2011;17:39-40
- Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011;98:1210-1224 https://doi.org/10.1002/bjs.7669
- Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology 2009;252:905-913 https://doi.org/10.1148/radiol.2523081676
- Kang CB, Xu HB, Wang SL, Rui JA. Treatment of large hepatoma by TACE in combination with RFA. Zhonghua Gandan Waike Zazhi 2007;13:828-830
- Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928 https://doi.org/10.1136/bmj.d5928
- Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-926 https://doi.org/10.1136/bmj.39489.470347.AD
- Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998;17:2815-2834 https://doi.org/10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
- Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16 https://doi.org/10.1186/1745-6215-8-16
- Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. The Cochrane Collaboration Web site. http://www.cochrane-handbook.org. Published September 2009
- Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 2013;31:426-432
- Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology 2012;262:689-700 https://doi.org/10.1148/radiol.11110637
- Morimoto M, Numata K, Kondou M, Nozaki A, Morita S, Tanaka K. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer 2010;116:5452-5460 https://doi.org/10.1002/cncr.25314
- Yang P, Liang M, Zhang Y, Shen B. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Adv Ther 2008;25:787-794 https://doi.org/10.1007/s12325-008-0079-x
- Aikata H, Shirakawa H, Takaki S, Uka K, Miki D, Yamashina K, et al. Radiofrequency ablation combined with transcatheter arterial chemoembolization for small hepatocellular carcinomas. Hepatology 2006;44:494A
- Lin JJ, Wu W, Jiang XF, Jin XJ, Lu LJ, Bao LW. [Clinical outcomes of radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: a single-center experience]. Zhonghua Zhong Liu Za Zhi 2013;35:144-147
- Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 2008;299:1669-1677 https://doi.org/10.1001/jama.299.14.1669
- Shen SQ, Xiang JJ, Xiong CL, Wu SM, Zhu SS. Intraoperative radiofrequency thermal ablation combined with portal vein infusion chemotherapy and transarterial chemoembolization for unresectable HCC. Hepatogastroenterology 2005;52:1403-1407
- Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation]. Ai Zheng 2005;24:827-833
- Shibata T, Shibata T, Maetani Y, Isoda H, Hiraoka M. Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode. Radiology 2006;238:346-353 https://doi.org/10.1148/radiol.2381041848
- Jiang G, Xu X, Ren S, Wang L. Combining transarterial chemoembolization with radiofrequency ablation for hepatocellular carcinoma. Tumour Biol 2014;35:3405-3408 https://doi.org/10.1007/s13277-013-1449-9
- Goldberg SN, Girnan GD, Lukyanov AN, Ahmed M, Monsky WL, Gazelle GS, et al. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology 2002;222:797-804 https://doi.org/10.1148/radiol.2223010861
- Seki T, Tamai T, Nakagawa T, Imamura M, Nishimura A, Yamashiki N, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 2000;89:1245-1251 https://doi.org/10.1002/1097-0142(20000915)89:6<1245::AID-CNCR8>3.0.CO;2-F
- Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2013;19:3872-3882 https://doi.org/10.3748/wjg.v19.i24.3872
- Lu Z, Wen F, Guo Q, Liang H, Mao X, Sun H. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials. Eur J Gastroenterol Hepatol 2013;25:187-194 https://doi.org/10.1097/MEG.0b013e32835a0a07
- Kong QF, Jiao JB, Chen QQ, Li L, Wang DG, Lv B. Comparative effectiveness of radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma. Tumour Biol 2014;35:2655-2659 https://doi.org/10.1007/s13277-013-1349-z
- Yan S, Xu D, Sun B. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci 2012;57:3026-3031 https://doi.org/10.1007/s10620-012-2212-6
- Yan S, Xu D, Sun B. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci 2013;58:2107-2113 https://doi.org/10.1007/s10620-013-2570-8
- Wang W, Shi J, Xie WF. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver Int 2010;30:741-749 https://doi.org/10.1111/j.1478-3231.2010.02221.x
- Liu Z, Gao F, Yang G, Singh S, Lu M, Zhang T, et al. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: an up-todate meta-analysis. Tumour Biol 2014;35:7407-7413 https://doi.org/10.1007/s13277-014-1976-z
- Spruance SL, Reid JE, Grace M, Samore M. Hazard ratio in clinical trials. Antimicrob Agents Chemother 2004;48:2787-2792 https://doi.org/10.1128/AAC.48.8.2787-2792.2004
Cited by
- Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization vol.14, pp.3, 2017, https://doi.org/10.3892/ol.2017.6489
- A concept for electromagnetic navigated targeting of liver tumors using an angiographic approach vol.27, pp.1, 2016, https://doi.org/10.1080/13645706.2017.1407798
- Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review vol.5, pp.2, 2018, https://doi.org/10.2217/hep-2018-0001
- A Glimpse on Trends and Characteristics of Recent Articles Published in the Korean Journal of Radiology vol.20, pp.12, 2019, https://doi.org/10.3348/kjr.2019.0928
- Curative Loco-regional Therapies for Early Hepatocellular Carcinoma: Is Combination Effective? vol.73, pp.3, 2019, https://doi.org/10.4166/kjg.2019.73.3.121
- Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations vol.44, pp.3, 2016, https://doi.org/10.1007/s00261-018-1831-6
- 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma vol.13, pp.3, 2016, https://doi.org/10.5009/gnl19024
- Current status of the combination therapy of transarterial chemoembolization and local ablation for hepatocellular carcinoma vol.44, pp.6, 2016, https://doi.org/10.1007/s00261-019-01943-2
- A new substage classification strategy for Barcelona Clinic Liver Cancer stage B patients with hepatocellular carcinoma vol.34, pp.11, 2019, https://doi.org/10.1111/jgh.14673
- Stereotactic Image-Guided Microwave Ablation for Malignant Liver Tumors—A Multivariable Accuracy and Efficacy Analysis vol.10, pp.None, 2016, https://doi.org/10.3389/fonc.2020.00842
- Curative-Intent Therapies in Localized Hepatocellular Carcinoma vol.21, pp.4, 2016, https://doi.org/10.1007/s11864-020-0725-3
- Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile? vol.97, pp.2, 2016, https://doi.org/10.1080/09553002.2021.1857453
- High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapy vol.27, pp.24, 2016, https://doi.org/10.3748/wjg.v27.i24.3630
- Thermal Ablation Versus Stereotactic Body Radiotherapy After Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis vol.217, pp.3, 2021, https://doi.org/10.2214/ajr.20.24117
- Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation vol.13, pp.21, 2016, https://doi.org/10.3390/cancers13215558
- Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis vol.19, pp.1, 2016, https://doi.org/10.1186/s12957-021-02188-4